相关实验视频
Updated: May 30, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
化疗相关认知障碍与阿尔茨海默病之间的生物学交叉点
Matthew Torre1, Camila A Zanella2, Mel B Feany2
1Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas; Center for Alzheimer's and Neurodegenerative Diseases, Baylor College of Medicine, Houston, Texas.
化疗可能通过影响共享的生物途径增加阿尔茨海默病 (AD) 风险. 了解这些联系对于公共卫生至关重要,特别是随着阿尔茨海默病和癌症幸存者人口的增加.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默病 (AD) 是老年人死亡的主要原因,预计到2060年,这种病例将增加一倍.
- 癌症幸存者越来越多,许多人在化疗后经历认知障碍.
- 识别AD可修改的风险因素是公共卫生的优先事项.
研究的目的:
- 探索阿尔茨海默病和化疗相关认知障碍之间的共享生物途径.
- 了解为什么一些化疗患者可能面临患AD的更高风险.
- 审查关键的分子和细胞机制涉及到这两个条件.
主要方法:
- 对连接AD和化疗诱导的认知缺陷的生物可信途径的文献综述.
- 对共同风险因素和潜在机制的分析.
- 综合当前关于神经炎症,氧化应激和遗传因素的研究.
主要成果:
- 共同的途径包括APOE E4等位基因,神经炎症,氧化应激,DNA损伤和线粒体功能障碍.
- 神经元/突触损失,细胞衰老,BDNF信号传递,白质损伤和血管功能障碍也与此有关.
- 病理和可转移元素的再激活代表了进一步的共同点.
结论:
- 化疗可能会通过共享的生物机制加剧或加速AD病理.
- 需要进一步的研究来阐明这些联系,并制定预防策略.
- 了解这些联系可以为患AD风险的癌症幸存者提供风险评估和管理信息.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
相关概念视频
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Psychoneuroimmunology: Diabetes and Cancer
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...